TICAGRACE 90 Ticagrelor (90mg) TICAGRACE 90 is a medication used to prevent blood clots and reduce the risk of cardiovascular events in patients with certain heart and blood vessel conditions. It is classified as an antiplatelet drug and is often prescribed to individuals who have had a heart attack, certain types of angina (chest pain), or who have undergone certain heart procedures, such as stent placement or coronary artery bypass grafting (CABG). Here are some key points about Ticagrelor: Mechanism of Action: TICAGRACE 90 belongs to a class of medications known as P2Y12 receptor inhibitors. It works by blocking the P2Y12 receptor on the surface of platelets, which are blood cells involved in clot formation. By inhibiting this receptor, Ticagrelor prevents platelets from clumping together and forming blood clots. Indications: Ticagrelor is primarily indicated for use in the following situations: After a Heart Attack (Myocardial Infarction): It is used in combination with aspirin to reduce the risk of recurrent cardiovascular events. After Certain Heart Procedures: It is prescribed in combination with aspirin for patients who have undergone procedures like coronary stent placement. In Certain Cases of Angina (Unstable Angina): Ticagrelor may be used in some cases of unstable angina or acute coronary syndrome. Dosage: The typical dosage of Ticagrelor is 90 mg taken orally twice daily. It is usually taken with or without food. Side Effects: Common side effects of TICAGRACE 90 may include bleeding, shortness of breath, headache, nausea, and an increased risk of bleeding. Serious bleeding, though less common, is a potential side effect that requires immediate medical attention. Precautions: Ticagrelor should be used with caution in patients at increased risk of bleeding, such as those with a history of bleeding disorders or recent surgery. It should not be used in patients with active pathological bleeding, severe liver disease, or a history of intracranial hemorrhage. Duration of Treatment: The duration of Ticagrelor treatment may vary depending on the patient's condition and the reason for its use. Some patients may need to take it for a few months, while others may require long-term therapy. Interactions: Ticagrelor can interact with other medications, so it's important for patients to inform their healthcare provider about all the drugs they are taking, including over-the-counter medications and herbal supplements. Discontinuation: Discontinuing Ticagrelor should be done under the guidance of a healthcare provider, as abruptly stopping the medication can increase the risk of blood clots and cardiovascular events. Ticagrelor is a valuable medication for individuals with certain cardiovascular conditions, as it helps reduce the risk of serious complications like heart attacks and strokes. However, its use should always be carefully considered and monitored by a healthcare provider to ensure that the benefits outweigh the potential risks and side effects, particularly the risk of bleeding. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/ticagrace-90-133388